TSHR and Graves disease: Since Graves’ disease is an autoimmune disorder associated with hyperthyroidism due to autoantibodies that bind to the thyroid-stimulating hormone receptor (TSHR) and trigger thyroid hormone release at the thyroid gland, Saxena et al. selected a TSHR antagonist as an output.